<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR25">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bernasconi</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Bernocchi</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Ye</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Le</surname>
    <given-names>MQ</given-names>
   </name>
   <name>
    <surname>Omokanye</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Carpentier</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Schon</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Saelens</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Staeheli</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Betbeder</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Lycke</surname>
    <given-names>N</given-names>
   </name>
  </person-group>
  <article-title>Porous nanoparticles with self-adjuvanting M2e-fusion protein and recombinant hemagglutinin provide strong and broadly protective immunity against influenza virus infections</article-title>
  <source>Front Immunol</source>
  <year>2018</year>
  <volume>9</volume>
  <fpage>2060</fpage>
  <pub-id pub-id-type="doi">10.3389/fimmu.2018.02060</pub-id>
  <?supplied-pmid 30271406?>
  <pub-id pub-id-type="pmid">30271406</pub-id>
 </element-citation>
</ref>
